Open AccessHepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study
Author(s) -
Gwang Hyeon Choi,
Eun Sun Jang,
Young Seok Kim,
Youn Jae Lee,
In Hee Kim,
Sung Bum Cho,
Han Chu Lee,
Jeong Won Jang,
Moran Ki,
Hoon Choi,
Dahye Baik,
SookHyang Jeong
Publication year - 2022
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v28.i30.4182
Subject(s) - medicine , hepatocellular carcinoma , hazard ratio , prospective cohort study , transplantation , liver transplantation , gastroenterology , cirrhosis , cohort , hepatitis c , proportional hazards model , surgery , confidence interval
Prospective studies of the long-term outcomes of patients with hepatitis C virus (HCV) infection after treatment with interferon-based therapy (IBT) or direct-acting antivirals (DAA) are limited in many Asian countries.